1. Home
  2. HAFN vs MMSI Comparison

HAFN vs MMSI Comparison

Compare HAFN & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hafnia Limited

HAFN

Hafnia Limited

HOLD

Current Price

$8.07

Market Cap

3.7B

Sector

N/A

ML Signal

HOLD

MMSI

Merit Medical Systems Inc.

HOLD

Current Price

$68.27

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAFN
MMSI
Founded
2012
1987
Country
Singapore
United States
Employees
4000
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.0B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
HAFN
MMSI
Price
$8.07
$68.27
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$100.38
AVG Volume (30 Days)
2.0M
709.8K
Earning Date
05-14-2026
04-30-2026
Dividend Yield
6.59%
N/A
EPS Growth
N/A
4.93
EPS
N/A
2.13
Revenue
N/A
$1,515,906,000.00
Revenue This Year
N/A
$8.78
Revenue Next Year
N/A
$5.76
P/E Ratio
$11.39
$32.19
Revenue Growth
N/A
11.75
52 Week Low
$4.12
$66.34
52 Week High
$8.52
$99.26

Technical Indicators

Market Signals
Indicator
HAFN
MMSI
Relative Strength Index (RSI) 63.08 39.87
Support Level $5.12 $66.76
Resistance Level N/A $71.57
Average True Range (ATR) 0.27 1.80
MACD 0.06 0.46
Stochastic Oscillator 70.35 34.62

Price Performance

Historical Comparison
HAFN
MMSI

About HAFN Hafnia Limited

Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Share on Social Networks: